680 related articles for article (PubMed ID: 16790461)
1. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME; Betsi GI; Athanasiou S
J Antimicrob Chemother; 2006 Aug; 58(2):266-72. PubMed ID: 16790461
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis.
Watson C; Calabretto H
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):262-72. PubMed ID: 17627679
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen peroxide producing lactobacilli in women with vaginal infections.
Mijac VD; Dukić SV; Opavski NZ; Dukić MK; Ranin LT
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):69-76. PubMed ID: 16814920
[TBL] [Abstract][Full Text] [Related]
6. Anti-Candida activity of beneficial vaginal lactobacilli in in vitro assays and in a murine experimental model.
De Gregorio PR; Silva JA; Marchesi A; Nader-Macías MEF
FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30689833
[TBL] [Abstract][Full Text] [Related]
7. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
Ray A; Ray S; George AT; Swaminathan N
Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
[TBL] [Abstract][Full Text] [Related]
8. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
9. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring?
Chassot F; Camacho DP; Patussi EV; Donatti L; Svidzinski TI; Consolaro ME
Contraception; 2010 Apr; 81(4):331-5. PubMed ID: 20227551
[TBL] [Abstract][Full Text] [Related]
10. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China.
Li J; Fan SR; Liu XP; Li DM; Nie ZH; Li F; Lin H; Huang WM; Zong LL; Jin JG; Lei H; Bai FY
Clin Infect Dis; 2008 Nov; 47(9):1119-25. PubMed ID: 18808351
[TBL] [Abstract][Full Text] [Related]
11. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.
Murina F; Graziottin A; Vicariotto F; De Seta F
J Clin Gastroenterol; 2014; 48 Suppl 1():S102-5. PubMed ID: 25291115
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of Candida albicans by human vaginal epithelial cells.
Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
[TBL] [Abstract][Full Text] [Related]
13. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
[TBL] [Abstract][Full Text] [Related]
14. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens.
Kaewsrichan J; Peeyananjarassri K; Kongprasertkit J
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):75-83. PubMed ID: 16965354
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
[TBL] [Abstract][Full Text] [Related]
16. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy.
Sun Z; Ge X; Qiu B; Xiang Z; Jiang C; Wu J; Li Y
Front Cell Infect Microbiol; 2023; 13():1123026. PubMed ID: 36816582
[TBL] [Abstract][Full Text] [Related]
17. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
[TBL] [Abstract][Full Text] [Related]
18. Genotype distribution of Candida albicans strains associated with different conditions of vulvovaginal candidiasis, as revealed by microsatellite typing.
Fan SR; Bai FY; Liao QP; Liu ZH; Li J; Liu XP
Sex Transm Infect; 2008 Apr; 84(2):103-6. PubMed ID: 17971371
[TBL] [Abstract][Full Text] [Related]
19. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
Reid G; Dols J; Miller W
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517
[TBL] [Abstract][Full Text] [Related]
20. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
